Skip to main content

Table 1 Overview of patient (T1, T2, T3) and caregiver (C0, C1, C2, C3) assessments

From: PerBrain: a multimodal approach to personalized tracking of evolving state-of-consciousness in brain-injured patients: protocol of an international, multicentric, observational study

C0

Before patients’ assessment

T1

1-2 m

from injury

C1

1-2w after results communi-cation

T2

4-7 m

from injury

C2

1-2w after results communi-cation

T3

9-12 m

from injury

C3

1-2w after results communi-cation

Personal data

FCV-19S

Religious/

spiritual information

BIPQ

EQ-5D-5L AcQoL

HADS

RS14

SOC-13

Treatment choices survey

Patient’s multimodal assessment a

+

Doctor’s communication of results to caregivers

FCV-19S

BIPQ

EQ-5D-5L HADS

+ qualitative interview (N = 9)

Patient’s multimodal assessment a

+

Doctor’s communication of results to caregivers

FCV-19S

BIPQ

EQ-5D-5L

AcQoL

HADS

Treatment

choices survey

Patient’s assessment at home

(CRS-R & GOS-E)

FCV-19S

Religious/

spiritual information

BIPQ

EQ-5D-5L AcQoL

HADS

RS14

SOC-13

  1. m months, w weeks, FCV-19S Fear of COVID-19 Scale; BIPQ Brief Illness Perception Questionnaire, EQ-5D-5L European Quality of Life-5 Dimensions, AcQoL Adult Carer Quality of Life Questionnaire, HADS Hospital Anxiety and Depression Scale, RS14 14-Item Resilience Scale, SOC-13 13-item Sense of Coherence Scale
  2. a Patient’s multimodal assessments at T1 and T2 include behavioral scales (CRS-R, GOS-E), qEEG, TMS-EEG, structural and functional MRI, and nasal respiration measurements (24h and odor dependent).